Concepedia

Andrew Goetz

AG

Statistics

Publications

14

Citations

1.7K

H-Index

13

Active since

2002

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

Case Western Reserve University

Wilford Hall Ambulatory Surgical Center

Brooke Army Medical Center

Andrew Goetz is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, cancer research, and pharmacology.

Top concepts

Publications per year

2002–2009

14

Publications

14

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

Anthony W. Tolcher, Stanton L. Gerson, Christiane Geyer et al. · British Journal of Cancer · 2003 · 366 citations · Full text

, , +18

Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors

Alain C. Mita, Louis Denis, Eric K. Rowinsky et al. · Clinical Cancer Research · 2009 · 328 citations

A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid Malignancies

Eric K. Rowinsky, Jinee Rizzo, Leonel Ochoa et al. · Journal of Clinical Oncology · 2002 · 132 citations

Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.

Chris H. Takimoto, Kira Glover-Cutter, Xiaoke Huang et al. · PubMed · 2003 · 129 citations

, , +11

A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies.

Amita Patnaik, Eric K. Rowinsky, Miguel A. Villalona et al. · PubMed · 2002 · 124 citations

, , +16

1–5 of 14